Hostname: page-component-78c5997874-xbtfd Total loading time: 0 Render date: 2024-11-17T23:03:16.419Z Has data issue: false hasContentIssue false
  • English
  • Français

The effect of cranberry consumption on lipid metabolism and inflammation in human apo A-I transgenic mice fed a high-fat and high-cholesterol diet

Published online by Cambridge University Press:  16 October 2020

Christian Caceres ,
Mi-Bo Kim ,
Minkyung Bae ,
Tho X. Pham ,
Yoojin Lee ,
Siqi Hu ,
Edward N. O’Neill ,
Bohkyung Kim ,
Young-Ki Park  and
Ji-Young Lee
Christian Caceres
Affiliation:
Department of Nutritional Sciences, University of Connecticut, Storrs, CT06269, USA
Mi-Bo Kim
Affiliation:
Department of Nutritional Sciences, University of Connecticut, Storrs, CT06269, USA
Minkyung Bae
Affiliation:
Department of Nutritional Sciences, University of Connecticut, Storrs, CT06269, USA Department of Food and Nutrition, Changwon National University, Changwon, Gyeongsangnam-do51140, South Korea
Tho X. Pham
Affiliation:
Department of Nutritional Sciences, University of Connecticut, Storrs, CT06269, USA
Yoojin Lee
Affiliation:
Department of Nutritional Sciences, University of Connecticut, Storrs, CT06269, USA
Siqi Hu
Affiliation:
Department of Nutritional Sciences, University of Connecticut, Storrs, CT06269, USA
Edward N. O’Neill
Affiliation:
Department of Nutritional Sciences, University of Connecticut, Storrs, CT06269, USA
Bohkyung Kim
Affiliation:
Department of Nutritional Sciences, University of Connecticut, Storrs, CT06269, USA Department of Food Science and Nutrition, Pusan National University, Busan46241, South Korea
Young-Ki Park
Affiliation:
Department of Nutritional Sciences, University of Connecticut, Storrs, CT06269, USA
Ji-Young Lee*
Affiliation:
Department of Nutritional Sciences, University of Connecticut, Storrs, CT06269, USA
*
*Corresponding author: Ji-Young Lee, fax +1 860 486 3674, email ji-young.lee@uconn.edu
Rights & Permissions [Opens in a new window]

Abstract

Lipid metabolism and inflammation contribute to CVD development. This study investigated whether the consumption of cranberries (CR; Vaccinium macrocarpon) can alter HDL metabolism and prevent inflammation in mice expressing human apo A-I transgene (hApoAITg), which have similar HDL profiles to those of humans. Male hApoAITg mice were fed a modified American Institute of Nutrition-93M high-fat/high-cholesterol diet (16 % fat, 0·25 % cholesterol, w/w; n 15) or the high-fat/high-cholesterol diet containing CR (5 % dried CR powder, w/w, n 16) for 8 weeks. There were no significant differences in body weight between the groups. Serum total cholesterol, non-HDL-cholesterol and TAG concentrations were significantly lower in the control than CR group with no significant differences in serum HDL-cholesterol and apoA-I. Mice fed CR showed significantly lower serum lecithin–cholesterol acyltransferase activity than the control. Liver weight and steatosis were not significantly different between the groups, but hepatic expression of genes involved in cholesterol metabolism was significantly lower in the CR group. In the epididymal white adipose tissue (eWAT), the CR group showed higher weights with decreased expression of genes for lipogenesis and fatty acid oxidation. The mRNA abundance of F4/80, a macrophage marker and the numbers of crown-like structures were less in the CR group. In the soleus muscle, the CR group also demonstrated higher expression of genes for fatty acid β-oxidation and mitochondrial biogenesis than those of the control. In conclusion, although CR consumption elicited minor effects on HDL metabolism, it prevented obesity-induced inflammation in eWAT with concomitant alterations in soleus muscle energy metabolism.

Keywords

CranberriesApoA-I transgenic miceInflammationHDL metabolism
Type
Full Papers
Information
British Journal of Nutrition , Volume 126 , Issue 2 , 28 July 2021 , pp. 183 - 190
Check for updates
Copyright
© The Author(s), 2020. Published by Cambridge University Press on behalf of The Nutrition Society

The prevalence of obesity continues to rise in the USA, and the Centers for Disease Control and Prevention estimate that more than one-third of US adults and approximately 12·7 million children and adolescents are obese(Reference Hurt, Kulisek and Buchanan1). The obesity epidemic has led to increasing rates of obesity-related pathological conditions, including CVD, type 2 diabetes, insulin resistance and certain cancers where disturbed lipid metabolism and chronic low-grade inflammation serve as the causal mediators in pathogenesis(Reference Hurt, Kulisek and Buchanan1,Reference Ruiz-Nunez, Pruimboom and Dijck-Brouwer2) . The accumulation of excess fat in adipose tissue promotes macrophage infiltration, which leads to the release of pro-inflammatory cytokines inducing low-grade inflammation(Reference Surmi and Hasty3,Reference Guilherme, Virbasius and Puri4) . There is an increasing need to identify food components with lipid-modulating and anti-inflammatory capabilities that effectively combat obesity-associated metabolic abnormalities and inflammation.

The consumption of fruits and vegetables has been suggested as a preventative measure of overweight and obesity(Reference Tetens and Alinia5). More specifically, anthocyanins, a type of polyphenols copiously present in certain berries with well-known antioxidant activity, have been reported to provide various health benefits for preventing obesity-related conditions, including insulin resistance, CVD and cancer(Reference Jennings, Welch and Spector6–Reference Thoppil, Bhatia and Barnes8). The American cranberry (CR; Vaccinium macrocarpon) is a rich source of polyphenols, including anthocyanins(Reference Côté, Caillet and Doyon9). Previous in vitro experiments suggest that CR may have anti-bacterial(Reference Huang, Nikolic and Pendland10), anti-carcinogenic(Reference Sun and Liu11) and anti-inflammatory properties(Reference McKay and Blumberg12). Kim et al.(Reference Kim, Ohn and Kim13) reported the potential anti-inflammatory ability of CR as the group observed reduced serum inflammatory markers in rats supplemented with freeze-dried CR powder. Anhê et al.(Reference Anhê, Roy and Pilon14) suggested CR extract might improve insulin sensitivity in diet-induced obese mice. However, CR research on metabolic dysfunctions and inflammation remains limited. In particular, there remains a gap in the evaluation of CR consumption on white adipose tissue morphology and functionality related to inflammation. Furthermore, although studies have shown that CR consumption increases plasma HDL-cholesterol concentrations in humans(Reference Ruel, Pomerleau and Couture15) and animals(Reference Kim, Jung and Kim16), mechanisms for the HDL-cholesterol-raising effect of CR have been limitedly understood. Therefore, the objective of this study was to assess lipid-modulating, with a primary focus on HDL metabolism, and anti-inflammatory effects of freeze-dried whole CR powder using mice expressing human apo A-I transgene (hApoAITg), which have similar HDL profiles to those of humans(Reference Rubin, Ishida and Clift17).

Materials and methods

Animal care and diet

hApoAITg mice (C57BL/6J background) were purchased from Jackson Laboratory. At 8 weeks of age, male hApoAITg mice were randomly assigned and fed ad libitum either a modified American Institute of Nutrition-93M high-fat/high-cholesterol control diet (16 % fat, 0·25 % cholesterol by weight, n 15) or the high-fat/high-cholesterol diet supplemented with CR (5 % whole CR powder by weight, n 16). The number of animals (n 15/group) was estimated based on the animal study that showed that 5 % of whole CR supplementation significantly increased plasma HDL-cholesterol levels(Reference Kim, Jung and Kim16) at an 80 % power with a two-tailed level of significance at P = 0·05. The standardised CR powder was kindly provided by Future Ceuticals. The experimental diet composition is listed in Table 1. The supplemental CR level (5 %) is equivalent to about 220 g of CR/d for humans(Reference Reagan-Shaw, Nihal and Ahmad18). Mice were housed under a 12 h light–12 h dark cycle with ad libitum access to food and water for 8 weeks of the feeding period. Body weight and food consumption were recorded weekly. At the end of the feeding period, mice were fasted for 4 h and subsequently anaesthetised by ketamine (110 mg/kg) and xylazine (10 mg/kg) (Henry Schein Animal Health). Blood was collected by performing cardiac puncture and centrifuged at 1500 g for 10 min for serum collection. Tissue samples, including the liver, small intestine, epididymal white adipose tissue (eWAT), soleus muscle and brown adipose tissue, were harvested and snap-frozen in liquid N2 for gene analysis or fixed in 10 % formalin for histological evaluations. Serum and tissue samples were stored at −80°C until use. The Institutional Animal Care and Use Committee at the University of Connecticut approved all animal procedures.

Table 1. Composition of the modified American Institute of Nutrition (AIN)-93M high-fat and high-cholesterol diet (HF/HC) and HF/HC supplemented with 5 % cranberry (CR) powder (g/kg diet)

Serum chemistry

Serum total cholesterol (TC) and TAG concentrations were enzymatically determined using Cholesterol Reagent (Pointe Scientific) and L-Type TG M kit (Wako Chemical), respectively, as we previously reported(Reference Kim, Ku and Pham19). Serum HDL-cholesterol concentration was measured after the precipitation of apoB-containing lipoproteins by using HDL-cholesterol precipitating Reagent Set (Pointe Scientific), and serum non-HDL-cholesterol was calculated by subtracting HDL-cholesterol from TC. Precinorm L (Roche) was used as a control. Serum levels of human apoA-I were measured using a human apoA-I ELISA kit (Thermo Scientific). Fluorometric lecithin–cholesterol acyltransferase (LCAT) and phospholipid transfer protein activity assay kits (Sigma Aldrich) were used to determine serum LCAT and PLTP activity, respectively.

Quantitative real-time PCR

Total RNA was extracted from tissue samples using TRIzol reagent (Invitrogen), and quantitative real-time PCR analysis was performed using SYBR Green and CFX96 real-time PCR detection system (Bio-Rad) as we previously described(Reference Yang, Seo and Nguyen20,Reference Ku, Pham and Park21) . Glyceraldehyde 3-phosphate dehydrogenase served as an internal control.

Histological analysis of the liver and epididymal white adipose tissue

Formalin-fixed liver and eWAT tissue sections were embedded in paraffin and cut into 5 μm sections for haematoxylin–eosin staining. All staining procedures were conducted at the Connecticut Veterinary Medical Diagnostic Laboratory (CVMDL). Tissue images were then viewed at various magnifications using an Axio Observer A1 microscope equipped with an AxioCam MRc camera (Carl Zeiss).

Statistical analysis

Unpaired t tests were conducted using GraphPad Prism 6.0 (GraphPad Software) to determine significant differences between groups. All data were considered statistically significant when the P value was <0·05 and are presented as mean values with their standard errors.

Results

The effect of cranberry supplementation on body weight and serum lipids

Control and CR-fed mice showed a gradual increase in body weight, but their body weights did not significantly differ between groups throughout the feeding period (Fig. 1(a)). Food intake was not different between groups (data not shown). Serum TC, non-HDL-cholesterol and TAG levels were significantly higher in the CR group than the control group, while there was no significant difference in serum HDL-cholesterol levels from each other (Fig. 1(b) and (c)). Also, serum apoA-I levels did not significantly differ between groups (Fig. 1(d)). While serum LCAT activity was significantly lower in the CR group than the control, serum phospholipid transfer protein activity was not significantly different between groups (Fig. 1(e) and (f)).

Fig. 1. Effect of cranberry (CR) supplementation on body weight and serum lipids in human apo A-I transgene (hApoAITg) mice. Male mice were fed a high-fat/high-cholesterol control or a high-fat/high-cholesterol diet containing 5 % CR by weight for 8 weeks. (a) Body weight of mice during the experimental period. , Control; , CR. (b) Serum concentration of total cholesterol (TC), non-HDL-cholesterol (non-HDL-C) and HDL-cholesterol (HDL-C). (c) Serum TAG levels. (d) Serum apoA-I. (e) Serum lecithin–cholesterol acyltransferase (LCAT) activity. (f) Serum phospholipid transfer protein (PLPT) activity. Data are mean values with their standard errors (n 15–16 per group). * Significantly different from control (P < 0·05).

The effect of cranberry supplementation on lipid metabolism in the liver and small intestine

Although liver weight tended towards an increase in the CR group compared with the control group, these two groups showed similar hepatic lipid accumulation (Fig. 2(a) and (b)). Hepatic expression of cholesterol metabolism-associated genes, such as LDL receptor (Ldlr), scavenger receptor class B type I, apoA-I and Lcat, was significantly reduced by CR supplementation, but no significant difference in ATP-binding cassette transporter A1 (Abca1) mRNA levels between groups was found (Fig. 2(c)). Also, the hepatic expression of sterol regulatory element-binding transcription factor 1c (Srebf-1c) showed a trend towards lower expression in the CR group than control, but there were no significant differences in the mRNA abundance of other lipogenic genes, such as fatty acid synthase (Fas), and stearoyl CoA desaturase 1, as well as genes related to fatty acid β-oxidation, for example, carnitine palmitoyltransferase 1α (Cpt-1α) and acyl-CoA oxidase 1 (Acox-1) (Table 2). Furthermore, the expression of genes responsible for intestinal cholesterol and lipoprotein metabolism, such as apoA-I, liver X receptor α, Abca1, Niemann-Pick C1-like 1, 3-hydroxy-3-methylglutaryl coenzyme A reductase and Ldlr, was not significantly altered by CR supplementation (Table 2).

Fig. 2. Effect of cranberry (CR) supplementation on hepatic lipid accumulation and gene expression in human apo A-I transgene (hApoAITg) mice. Male mice were fed a high-fat/high-cholesterol control or a high-fat/high-cholesterol diet containing 5 % CR by weight for 8 weeks. (a) Liver weight. (b) Representative images of liver sections stained with haematoxylin and eosin. (c) Hepatic mRNA expression of genes involved in cholesterol metabolism. n 15–16 per group. * Significantly different from control (P < 0·05). Ldlr, LDL receptor; Sr-b1, scavenger receptor class B type I; Abca1, ATP-binding cassette transporter A1; Lcat, lecithin–cholesterol acyltransferase.

Table 2. Gene expressions in the liver, small intestine and brown adipose tissue (BAT) of human apo A-I transgene (hApoA-ITg) mice fed high-fat/high-cholesterol diet (HF/HC) and HF/HC supplemented with cranberries (HF/HC-CR) for 8 weeks (fold of control)

(Mean values with their standard errors)

Cpt-1α, carnitine palmitoyltransferase 1α; Acox-1, acyl-CoA oxidase 1; Fas, fatty acid synthase; Scd-1, stearoyl CoA desaturase 1; Srebf-1c, sterol regulatory element-binding transcription factor 1c; Apoa-I, human apo A-I; Lxrα, liver X receptor α; Abca1, ATP-binding cassette transporter A1; Npc1l1, Niemann-Pick C1-like 1; Hmgr, 3-hydroxy-3-methylglutaryl coenzyme A reductase; Ldlr, LDL receptor; Pgc-1α, PPARγ coactivator; Tfam, mitochondrial transcription factor A.

* P values indicate significant difference from HF/HC control (P < 0·05).

The effect of cranberry supplementation on lipid metabolism and inflammation in epididymal white adipose tissue

While eWAT weight was significantly higher in the CR group than the control, the expression of genes involved in fatty acid synthesis, such as Srebf-1c and Fas, in the eWAT was significantly reduced by CR supplementation (Fig. 3(a) and (b)). Also, the expression of fatty acid β-oxidation genes, such as Cpt-1α, and Acox-1, was significantly lower in the CR group compared with the control mice (Fig. 3(c)). Mice on the CR diet had significantly lower eWAT mRNA levels of F4/80, a macrophage marker, than those of the control, although the expression of M1 macrophage marker, for example, chemokine (C-C motif) ligand 2 (Ccl-2), was not altered by CR supplementation (Fig. 3(d)). Furthermore, histological analysis of eWAT revealed more macrophage infiltration in the control group than the CR group (Fig. 3(e)).

Fig. 3. Effect of cranberry (CR) supplementation on lipid metabolism and inflammation in epididymal white adipose tissue (eWAT) of human apo A-I transgene (hApoAITg) mice. Male mice were fed a high-fat/high-cholesterol control or a high-fat/high-cholesterol diet containing 5 % CR by weight for 8 weeks. (a) eWAT weight. (b) eWAT mRNA expression of genes related to fatty acid synthesis. (c) eWAT mRNA expression of fatty acid β-oxidation genes. (d) eWAT mRNA expression of inflammatory genes. (e) Representative images of eWAT sections stained with haematoxylin and eosin. n 15–16 per group. * Significantly different from control (P < 0·05). Srebf-1c, sterol regulatory element-binding transcription factor 1c; Fas, fatty acid synthase; Cpt-1a, carnitine palmitoyltransferase 1α; Acox-1, acyl-CoA oxidase 1; Ccl-2, chemokine (C-C motif) ligand 2.

The effect of cranberry supplementation on the expression of energy utilisation genes in soleus muscle and brown adipose tissue

Fatty acid oxidation and mitochondrial biogenesis in skeletal muscle and brown adipose tissue have a substantial impact on energy expenditure along with eWAT(Reference Zhao, Huang and Du22). Therefore, we next evaluated the effect of CR on the expression of genes related to fatty acid β-oxidation and mitochondrial biogenesis in soleus muscle and brown adipose tissue. The mRNA abundance of fatty acid β-oxidation genes, that is, Cpt-1a, Cpt-1b, Acox-1 and mitochondrial uncoupling protein 3 (Ucp-3) was significantly higher in the CR group than the control group, while Ucp-2 mRNA tended towards an increase in the CR group compared with the control group in the soleus muscle (Fig. 4(a)). The mRNA levels of Ppara and PPARδ (Ppard), transcription factors involved in fatty acid oxidation and uncoupling, were significantly higher in the mice fed CR than control mice (Fig. 4(b)). Lipoprotein lipase (Lpl), an enzyme that hydrolyses TAG in lipoproteins so that NEFA can be taken into muscle, showed a significantly higher expression in the CR group than the control group (Fig. 4(c)). While the expression of a mitochondrial biogenesis gene, mitochondrial transcription factor A (Tfam), in soleus muscle was significantly increased by CR compared with the control group, there were no significant differences in the expression of PPARγ coactivator 1α (Ppargc-1a) and Pgc-1β (Ppargc-1b), which are genes important for mitochondrial biogenesis(Reference Villarroya, Iglesias and Giralt23) (Fig. 4(d)). Serving as transcriptional regulators to UCP-2 and UCP-3 expression, the PPAR promote lipid metabolism in WAT.

Fig. 4. Effect of cranberry (CR) supplementation on energy utilisation genes in the soleus muscle of human apo A-I transgene (hApoAITg) mice. Male mice were fed a high-fat/high-cholesterol control or a high-fat/high-cholesterol diet containing 5 % CR by weight for 8 weeks. (a) mRNA expression of genes for fatty acid β-oxidation and uncoupling. (b) Pparα (Ppara) and Pparδ (Ppard) mRNA. (c) Lipoprotein lipase (Lpl) mRNA. (d) mRNA abundance of genes involved in mitochondrial biogenesis. n 15–16 per group. * Significantly different from control (P < 0·05). Cpt-1a, carnitine palmitoyltransferase 1α; Cpt-1b, carnitine palmitoyltransferase 1β; Acox-1, acyl-CoA oxidase 1; Ucp-2, uncoupling protein 2; Ucp-3, uncoupling protein 3; Ppargc1a, PPARγ coactivator 1α; Ppargc1b, PPARγ coactivator 1β; Tfam, mitochondrial transcription factor A.

In the brown adipose tissue, Tfam expression showed a trend towards an increase in the CR group compared with the control group, but mRNA levels of Pgc-1α and Pgc-1β were not significantly different between the two groups (Table 2).

Discussion

The development of pathological conditions, including CVD, is an apparent manifestation of an obese state due to high lipid burden at adipose tissue and consequent low-grade inflammation(Reference Bastien, Poirier and Lemieux24). To meet a growing need for the identification of foods capable of preventing and/or ameliorating dyslipidaemia and chronic inflammation, the first objective of the current study was to assess the effects of CR consumption on HDL metabolism of hApoAITg mice. Also, our second goal was to determine the potential anti-inflammatory effects of CR in metabolically active tissues, including the liver, eWAT and skeletal muscle in hApoAITg mice. Although CR consumption has been shown to increase plasma HDL-cholesterol levels in humans(Reference Ruel, Pomerleau and Couture15) and animals(Reference Kim, Jung and Kim16), we did not find the noteworthy effects of CR on HDL metabolism. However, CR consumption mitigated obesity-induced inflammation in WAT.

The effect of CR consumption on circulating TAG levels is controversial. In a double-blind, placebo-controlled, parallel-arm human study performed by Novotny et al. (Reference Novotny, Baer and Khoo25), serum TAG levels were significantly lower in the treatment group than in the placebo group after having consumed 240 ml of low-energy CR juice twice daily for 8 weeks. However, in a similar study lasting for 28 d, Caron et al. (Reference Caron, Kautza and Wilson26) did not find alterations in TAG levels in the low-energy CR juice treatment group. In the present study, we did not observe a hypolipidemic effect of CR powder. Instead, significantly greater serum TAG were found in the CR group than in the control mice. Our results show apo-B-containing cholesterol was significantly higher in the CR-fed mice than in the control mice without significantly altering TC. Kim et al.(Reference Kim, Jung and Kim27) reported that rats fed an atherogenic diet supplemented with 5 % freeze-dried CR powder tended to have greater TAG levels compared with the control animals. They also observed a tendency towards higher LDL-cholesterol levels in CR-fed rats than in control, although no difference in TC was found between the groups. The discrepancy between studies on the effects of CR on serum TAG, TC and LDL-cholesterol suggests that CR may have different effects on serum lipid profile depending on the amount supplemented, the form of consumption, and animal species.

The prevention of monocyte recruitment and consequent inflammation in WAT is essential to preventing the development of obesity-related pathological conditions, including insulin resistance(Reference Guilherme, Virbasius and Puri4). Despite no changes in body weight, CR supplementation prevented eWAT inflammation, as the degree of macrophage infiltration was lower compared with the control group. In the CR group, mRNA level of macrophage marker F4/80 was significantly reduced, while a trending decrease and increases in the mRNA levels of Ccl-2 and an anti-inflammatory cytokine, IL-10 (data not shown), were observed. Macrophage infiltration may be morphologically determined by the presence of crown-like structures in WAT(Reference Murano, Barbatelli and Parisani28). Crown-like structures obtain their name from the manner in which macrophages surround metabolically stressed adipocytes and consume dying cells. Macrophage infiltration was detected in both the CR-fed and control mice; however, the infiltration tended to be more severe in the control mice, which is in accordance with the F4/80 and Ccl-2 expression levels. These results were observed without a significant difference in average adipocyte diameter between the groups (data not shown), possibly suggesting that WAT inflammation may be partly influenced by factors additional to adipocyte hypertrophy, including the rate of hyperplasia or overall storage capacity of WAT(Reference Lee, Wu and Fried29).

We previously demonstrated that altered expression of metabolic genes in skeletal muscle might promote an anti-inflammatory condition in WAT by decreasing macrophage infiltration through increased energy utilisation at the muscle(Reference Benn, Kim and Park30). In the soleus muscle, we found that mRNA abundances of genes involved in β-oxidation, including Cpt-1a, Cpt-1b and Acox-1, were significantly greater in mice fed CR than the control mice. Furthermore, inductions of Ppara, Ppard and Lpl expression were greater in the CR-fed mice compared with the control. Ucp-3 expression significantly increased in the CR-fed mice, with Ucp-2 tending to increase in the CR group compared with the control mice. Uncoupling proteins disrupt the coupling of electron transport and oxidative phosphorylation and therefore stimulate substrate oxidation with energy dissipated as heat rather than supporting ATP synthesis(Reference Jia, Zhang and Ge31). The benefits of uncoupling are reported by Clapham et al.(Reference Clapham, Arch and Chapman32) that demonstrated protection against obesity with lower fasting serum glucose and insulin in mice overexpressing Ucp-3 in skeletal muscle. The expression of genes involved in mitochondrial biogenesis was also measured with Tfam expression significantly increased in the CR-fed mice and a tendency towards an increase in Pgc-1α and Pgc-1β compared with the control mice. Also, we found that the expression of metabolic genes, including Fas, Srebf-1c, Acox-1 and Cpt-1a, was significantly down-regulated in the CR-fed mice in WAT. Although further investigations are required to directly attribute CR consumption to increases in the expression of metabolic genes in skeletal muscle, these results suggest CR may have the potential to influence WAT inflammation via energy modulation in skeletal muscle.

ApoA-I is the major protein component of HDL and is primarily expressed in the liver and small intestine(Reference Haas, Mazza and Wong33). It plays a key role in reverse cholesterol transport by serving as the initial acceptor of unesterified cholesterol exported by ABCA1 from peripheral cells, including foam cells(Reference Curtiss, Valenta and Hime34). The importance of apoA-I is highlighted by the finding that low levels of apoA-I associate more strongly with CVD risk than HDL-cholesterol levels(Reference Florvall, Basu and Larsson35). Moreover, overexpression of apoA-I has proven to promote macrophage-specific reverse cholesterol transport(Reference Zhang, Zanotti and Reilly36). Interestingly, we found that hepatic apoA-I expression was significantly decreased in the CR-fed mice, while no significant difference was found in the serum apoA-I level. To the best of our knowledge, we are the first that reports an effect or lack thereof of whole CR powder on circulating apoA-I levels. We attribute the lack of modification in the serum apoA-I level to an insufficient length and/or amount of treatment. Although administered in a different form, Shidfar et al. (Reference Shidfar, Heydari and Hajimiresmaiel37) reported a significant increase in serum apoA-I in male type 2 diabetic patients who had received a cup of CR juice per d for 12 weeks. Therefore, another investigation with increased dose or duration using whole CR powder may be required to observe a potential increase in serum apoA-I. The decrease in apoA-I expression in the liver of CR-fed mice is unlikely to result from CR directly and is more plausibly related to the inflammatory response. The reciprocal effects of apoA-I on WAT metabolism and function, including its anti-inflammatory effects, are generally accepted(Reference Sultana, Cochran and Tabet38,Reference Vanella, Li and Kim39) . Umemoto et al. (Reference Umemoto, Han and Mitra40) demonstrated anti-inflammatory effects of apoA-I using cultured adipocytes and adipocytes from obesity-induced hApoAITg mice. It is possible that the decreased expression of hepatic apoA-I in the CR-fed mice could have resulted from a decreased necessity for apoA-I due to less adipocyte stress. Alternatively, the decreased expression of apoA-I in the liver of CR-fed mice may be explained by the adipocyte’s ability to recycle apoA-I. Several investigators have reported the adipocyte’s ability to internalise and secrete apoA-I(Reference Verghese, Arrese and Howard41,Reference Howard, Verghese and Arrese42) . Although the clinical significance of apoA-I recycling by adipocytes remains unclear, apoA-I may be present in adipocytes in the absence of its mRNA abundance(Reference Wang, Peng and Yi43). This peripheral tissue-dependent transcription of apoA-I in the liver (and possibly small intestine) is supported by the fact that the main function of apoA-I is to mediate reverse cholesterol transport from peripheral tissues. Therefore, the decreased expression of apoA-I in the CR-fed mice of the present study may have resulted from a decreased demand in adipocytes mediated by apoA-I recycling.

This study is among the first to investigate the potential health benefits of CR supplementation by altering HDL metabolism and chronic inflammation. The effects of CR supplementation on HDL metabolism were minimal in our study. However, we found that CR consumption prevents chronic inflammation in WAT, although exact mechanisms of action are not clear. Future investigations are required to identify the underlying mechanism of actions by which CR exerts such an anti-inflammatory effect in other diet-induced obesity mouse models, such as mice fed a diet rich in fat and sucrose.

Acknowledgements

This work was supported by a Nutricia Research Foundation grant to J. L.

C. C., M. B., T. X. P., Y. L., S. H., E. N. O. and B. K. carried out experiments and performed data analysis; C. C., M.-B. K., Y.-K. P. and J.-Y. L. wrote the manuscript and J.-Y. L. designed and led the study. All authors read the manuscript.

All authors claim no conflicts of interest.

Supplementary material

For supplementary materials referred to in this article, please visit https://doi.org/10.1017/S0007114520004080

References

Hurt, RT, Kulisek, C, Buchanan, LA, et al. (2010) The obesity epidemic: challenges, health initiatives, and implications for gastroenterologists. Gastroenterol Hepatol (N Y) 6, 780–792.Google ScholarPubMed
Ruiz-Nunez, B, Pruimboom, L, Dijck-Brouwer, DA, et al. (2013) Lifestyle and nutritional imbalances associated with Western diseases: causes and consequences of chronic systemic low-grade inflammation in an evolutionary context. J Nutr Biochem 24, 1183–1201.CrossRefGoogle Scholar
Surmi, BK & Hasty, AH (2008) Macrophage infiltration into adipose tissue: initiation, propagation and remodeling. Future Lipidol 3, 545–556.CrossRefGoogle ScholarPubMed
Guilherme, A, Virbasius, JV, Puri, V, et al. (2008) Adipocyte dysfunctions linking obesity to insulin resistance and type 2 diabetes. Nat Rev Mol Cell Biol 9, 367–377.CrossRefGoogle ScholarPubMed
Tetens, I & Alinia, S (2009) The role of fruit consumption in the prevention of obesity. J Hortic Sci Biotechnol 84, 47–51.CrossRefGoogle Scholar
Jennings, A, Welch, AA, Spector, T, et al. (2014) Intakes of anthocyanins and flavones are associated with biomarkers of insulin resistance and inflammation in women. J Nutr 144, 202–208.CrossRefGoogle ScholarPubMed
Krga, I, Monfoulet, L-E, Konic-Ristic, A, et al. (2016) Anthocyanins and their gut metabolites reduce the adhesion of monocyte to TNFα-activated endothelial cells at physiologically relevant concentrations. Arch Biochem Biophys 599, 51–59.CrossRefGoogle ScholarPubMed
Thoppil, RJ, Bhatia, D, Barnes, KF et al. (2012) Black currant anthocyanins abrogate oxidative stress through Nrf2-mediated antioxidant mechanisms in a rat model of hepatocellular carcinoma. Curr Cancer Drug Targets 12, 1244–1257.Google Scholar
Côté, J, Caillet, S, Doyon, G, et al. (2010) Bioactive compounds in cranberries and their biological properties. Crit Rev Food Sci Nutr 50, 666–679.CrossRefGoogle ScholarPubMed
Huang, Y, Nikolic, D, Pendland, S, et al. (2009) Effects of cranberry extracts and ursolic acid derivatives on P-fimbriated Escherichia coli, COX-2 activity, pro-inflammatory cytokine release and the NF-κβ transcriptional response in vitro . Pharm Biol 47, 18–25.CrossRefGoogle ScholarPubMed
Sun, J & Liu, RH (2006) Cranberry phytochemical extracts induce cell cycle arrest and apoptosis in human MCF-7 breast cancer cells. Cancer Lett 241, 124–134.CrossRefGoogle ScholarPubMed
McKay, DL & Blumberg, JB (2007) Cranberries (Vaccinium macrocarpon) and cardiovascular disease risk factors. Nutr Rev 65, 490–502.CrossRefGoogle ScholarPubMed
Kim, MJ, Ohn, J, Kim, JH, et al. (2011) Effects of freeze-dried cranberry powder on serum lipids and inflammatory markers in lipopolysaccharide treated rats fed an atherogenic diet. Nutr Res Pract 5, 404–411.CrossRefGoogle ScholarPubMed
Anhê, FF, Roy, D, Pilon, G, et al. (2015) A polyphenol-rich cranberry extract protects from diet-induced obesity, insulin resistance and intestinal inflammation in association with increased Akkermansia spp. population in the gut microbiota of mice. Gut 64, 872–883.CrossRefGoogle ScholarPubMed
Ruel, G, Pomerleau, S, Couture, P, et al. (2006) Favourable impact of low-calorie cranberry juice consumption on plasma HDL-cholesterol concentrations in men. Br J Nutr 96, 357–364.CrossRefGoogle ScholarPubMed
Kim, MJ, Jung, HN, Kim, KN, et al. (2008) Effects of cranberry powder on serum lipid profiles and biomarkers of oxidative stress in rats fed an atherogenic diet. Nutr Res Pract 2, 158–164.CrossRefGoogle ScholarPubMed
Rubin, EM, Ishida, BY, Clift, SM, et al. (1991) Expression of human apolipoprotein A-I in transgenic mice results in reduced plasma levels of murine apolipoprotein A-I and the appearance of two new high density lipoprotein size subclasses. Proc Natl Acad Sci U S A 88, 434–438.CrossRefGoogle ScholarPubMed
Reagan-Shaw, S, Nihal, M & Ahmad, N (2008) Dose translation from animal to human studies revisited. FASEB J 22, 659–661.CrossRefGoogle ScholarPubMed
Kim, B, Ku, CS, Pham, TX, et al. (2013) Aronia melanocarpa (chokeberry) polyphenol-rich extract improves antioxidant function and reduces total plasma cholesterol in apolipoprotein E knockout mice. Nutr Res 33, 406–413.CrossRefGoogle ScholarPubMed
Yang, Y, Seo, JM, Nguyen, A, et al. (2011) Astaxanthin-rich extract from the green alga Haematococcus pluvialis lowers plasma lipid concentrations and enhances antioxidant defense in apolipoprotein E knockout mice. J Nutr 141, 1611–1617.CrossRefGoogle ScholarPubMed
Ku, CS, Pham, TX, Park, Y, et al. (2013) Edible blue–green algae reduce the production of pro-inflammatory cytokines by inhibiting NF-κB pathway in macrophages and splenocytes. Biochim Biophys Acta 1830, 2981–2988.CrossRefGoogle ScholarPubMed
Zhao, L, Huang, Y & Du, M (2019) Farm animals for studying muscle development and metabolism: dual purposes for animal production and human health. Anim Front 9, 21–27.CrossRefGoogle ScholarPubMed
Villarroya, F, Iglesias, R & Giralt, M (2007) PPARs in the control of uncoupling proteins gene expression. PPAR Res 2007, 74364.CrossRefGoogle ScholarPubMed
Bastien, M, Poirier, P, Lemieux, I, et al. (2014) Overview of epidemiology and contribution of obesity to cardiovascular disease. Prog Cardiovasc Dis 56, 369–381.CrossRefGoogle ScholarPubMed
Novotny, JA, Baer, DJ, Khoo, C, et al. (2015) Cranberry juice consumption lowers markers of cardiometabolic risk, including blood pressure and circulating C-reactive protein, triglyceride, and glucose concentrations in adults. J Nutr 145, 1185–1193.CrossRefGoogle ScholarPubMed
Caron, A, Kautza, B & Wilson, T (2005) Cholesterol lowering effects of low calorie cranberry juice in humans. FASEB J 19, A1009–A1010.Google Scholar
Kim, MJ, Jung, HN, Kim, KN, et al. (2008) Effects of cranberry powder on serum lipid profiles and biomarkers of oxidative stress in rats fed an atherogenic diet. Nutr Res Pract 2, 158–164.CrossRefGoogle ScholarPubMed
Murano, I, Barbatelli, G, Parisani, V, et al. (2008) Dead adipocytes, detected as crown-like structures, are prevalent in visceral fat depots of genetically obese mice. J Lipid Res 49, 1562–1568.CrossRefGoogle ScholarPubMed
Lee, M-J, Wu, Y & Fried, SK (2010) Adipose tissue remodeling in pathophysiology of obesity. Curr Opin Clin Nutr Metab Care 13, 371.CrossRefGoogle ScholarPubMed
Benn, T, Kim, B, Park, YK, et al. (2014) Polyphenol-rich blackcurrant extract prevents inflammation in diet-induced obese mice. J Nutr Biochem 25, 1019–1025.CrossRefGoogle ScholarPubMed
Jia, JJ, Zhang, X, Ge, CR, et al. (2009) The polymorphisms of UCP2 and UCP3 genes associated with fat metabolism, obesity and diabetes. Obes Rev 10, 519–526.CrossRefGoogle ScholarPubMed
Clapham, JC, Arch, JR, Chapman, H, et al. (2000) Mice overexpressing human uncoupling protein-3 in skeletal muscle are hyperphagic and lean. Nature 406, 415–418.CrossRefGoogle ScholarPubMed
Haas, MJ, Mazza, AD, Wong, NC, et al. (2012) Inhibition of apolipoprotein A-I gene expression by obesity-associated endocannabinoids. Obesity (Silver Spring) 20, 721–729.CrossRefGoogle ScholarPubMed
Curtiss, LK, Valenta, DT, Hime, NJ, et al. (2006) What is so special about apolipoprotein AI in reverse cholesterol transport? Arterioscler Thromb Vasc Biol 26, 12–19.CrossRefGoogle ScholarPubMed
Florvall, G, Basu, S & Larsson, A (2006) Apolipoprotein A1 is a stronger prognostic marker than are HDL and LDL cholesterol for cardiovascular disease and mortality in elderly men. J Gerontol A Biol Sci Med Sci 61, 1262–1266.CrossRefGoogle ScholarPubMed
Zhang, Y, Zanotti, I, Reilly, MP, et al. (2003) Overexpression of apolipoprotein A-I promotes reverse transport of cholesterol from macrophages to feces in vivo . Circulation 108, 661–663.CrossRefGoogle ScholarPubMed
Shidfar, F, Heydari, I, Hajimiresmaiel, SJ, et al. (2012) The effects of cranberry juice on serum glucose, apoB, apoA-I, Lp(a), and Paraoxonase-1 activity in type 2 diabetic male patients. J Res Med Sci 17, 355–360.Google Scholar
Sultana, A, Cochran, BJ, Tabet, F, et al. (2016) Inhibition of inflammatory signaling pathways in 3T3-L1 adipocytes by apolipoprotein A-I. FASEB J 30, 2324–2335.CrossRefGoogle ScholarPubMed
Vanella, L, Li, M, Kim, D, et al. (2012) ApoA1: mimetic peptide reverses adipocyte dysfunction in vivo and in vitro via an increase in heme oxygenase (HO-1) and Wnt10b. Cell Cycle 11, 706–714.CrossRefGoogle ScholarPubMed
Umemoto, T, Han, CY, Mitra, P, et al. (2013) Apolipoprotein AI and high-density lipoprotein have anti-inflammatory effects on adipocytes via cholesterol transporters: ATP-binding cassette A-1, ATP-binding cassette G-1, and scavenger receptor B-1. Circ Res 112, 1345–1354.CrossRefGoogle ScholarPubMed
Verghese, PB, Arrese, EL, Howard, AD, et al. (2008) Brefeldin A inhibits cholesterol efflux without affecting the rate of cellular uptake and re-secretion of apolipoprotein A-I in adipocytes. Arch Biochem Biophys 478, 161–166.CrossRefGoogle ScholarPubMed
Howard, AD, Verghese, PB, Arrese, EL, et al. (2011) The beta-subunit of ATP synthase is involved in cellular uptake and resecretion of apoA-I but does not control apoA-I-induced lipid efflux in adipocytes. Mol Cell Biochem 348, 155–164.CrossRefGoogle Scholar
Wang, S, Peng, DQ & Yi, Y (2016) The unsolved mystery of apoA-I recycling in adipocyte. Lipids Health Dis 15, 35.CrossRefGoogle ScholarPubMed
Figure 0

Table 1. Composition of the modified American Institute of Nutrition (AIN)-93M high-fat and high-cholesterol diet (HF/HC) and HF/HC supplemented with 5 % cranberry (CR) powder (g/kg diet)

Figure 1

Fig. 1. Effect of cranberry (CR) supplementation on body weight and serum lipids in human apo A-I transgene (hApoAITg) mice. Male mice were fed a high-fat/high-cholesterol control or a high-fat/high-cholesterol diet containing 5 % CR by weight for 8 weeks. (a) Body weight of mice during the experimental period. , Control; , CR. (b) Serum concentration of total cholesterol (TC), non-HDL-cholesterol (non-HDL-C) and HDL-cholesterol (HDL-C). (c) Serum TAG levels. (d) Serum apoA-I. (e) Serum lecithin–cholesterol acyltransferase (LCAT) activity. (f) Serum phospholipid transfer protein (PLPT) activity. Data are mean values with their standard errors (n 15–16 per group). * Significantly different from control (P < 0·05).

Figure 2

Fig. 2. Effect of cranberry (CR) supplementation on hepatic lipid accumulation and gene expression in human apo A-I transgene (hApoAITg) mice. Male mice were fed a high-fat/high-cholesterol control or a high-fat/high-cholesterol diet containing 5 % CR by weight for 8 weeks. (a) Liver weight. (b) Representative images of liver sections stained with haematoxylin and eosin. (c) Hepatic mRNA expression of genes involved in cholesterol metabolism. n 15–16 per group. * Significantly different from control (P < 0·05). Ldlr, LDL receptor; Sr-b1, scavenger receptor class B type I; Abca1, ATP-binding cassette transporter A1; Lcat, lecithin–cholesterol acyltransferase.

Figure 3

Table 2. Gene expressions in the liver, small intestine and brown adipose tissue (BAT) of human apo A-I transgene (hApoA-ITg) mice fed high-fat/high-cholesterol diet (HF/HC) and HF/HC supplemented with cranberries (HF/HC-CR) for 8 weeks (fold of control)(Mean values with their standard errors)

Figure 4

Fig. 3. Effect of cranberry (CR) supplementation on lipid metabolism and inflammation in epididymal white adipose tissue (eWAT) of human apo A-I transgene (hApoAITg) mice. Male mice were fed a high-fat/high-cholesterol control or a high-fat/high-cholesterol diet containing 5 % CR by weight for 8 weeks. (a) eWAT weight. (b) eWAT mRNA expression of genes related to fatty acid synthesis. (c) eWAT mRNA expression of fatty acid β-oxidation genes. (d) eWAT mRNA expression of inflammatory genes. (e) Representative images of eWAT sections stained with haematoxylin and eosin. n 15–16 per group. * Significantly different from control (P < 0·05). Srebf-1c, sterol regulatory element-binding transcription factor 1c; Fas, fatty acid synthase; Cpt-1a, carnitine palmitoyltransferase 1α; Acox-1, acyl-CoA oxidase 1; Ccl-2, chemokine (C-C motif) ligand 2.

Figure 5

Fig. 4. Effect of cranberry (CR) supplementation on energy utilisation genes in the soleus muscle of human apo A-I transgene (hApoAITg) mice. Male mice were fed a high-fat/high-cholesterol control or a high-fat/high-cholesterol diet containing 5 % CR by weight for 8 weeks. (a) mRNA expression of genes for fatty acid β-oxidation and uncoupling. (b) Pparα (Ppara) and Pparδ (Ppard) mRNA. (c) Lipoprotein lipase (Lpl) mRNA. (d) mRNA abundance of genes involved in mitochondrial biogenesis. n 15–16 per group. * Significantly different from control (P < 0·05). Cpt-1a, carnitine palmitoyltransferase 1α; Cpt-1b, carnitine palmitoyltransferase 1β; Acox-1, acyl-CoA oxidase 1; Ucp-2, uncoupling protein 2; Ucp-3, uncoupling protein 3; Ppargc1a, PPARγ coactivator 1α; Ppargc1b, PPARγ coactivator 1β; Tfam, mitochondrial transcription factor A.

Supplementary material: File

Caceres et al. supplementary material

Caceres et al. supplementary material

Download Caceres et al. supplementary material(File)
File 18.3 KB